These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22095692)

  • 21. Truncated peroxisome proliferator-activated receptor-γ coactivator 1α splice variant is severely altered in Huntington's disease.
    Johri A; Starkov AA; Chandra A; Hennessey T; Sharma A; Orobello S; Squitieri F; Yang L; Beal MF
    Neurodegener Dis; 2011; 8(6):496-503. PubMed ID: 21757867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
    Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
    Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation.
    Lee M; Ban JJ; Chung JY; Im W; Kim M
    PLoS One; 2018; 13(5):e0195968. PubMed ID: 29742127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression.
    Di Cristo F; Finicelli M; Digilio FA; Paladino S; Valentino A; Scialò F; D'Apolito M; Saturnino C; Galderisi U; Giordano A; Melone MAB; Peluso G
    J Cell Physiol; 2019 Jun; 234(6):9233-9246. PubMed ID: 30362565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial targeted antioxidants as potential therapy for huntington's disease.
    Upadhayay S; Kumar P
    Pharmacol Rep; 2024 Aug; 76(4):693-713. PubMed ID: 38982016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.
    McMeekin LJ; Li Y; Fox SN; Rowe GC; Crossman DK; Day JJ; Li Y; Detloff PJ; Cowell RM
    J Neurosci; 2018 Mar; 38(13):3273-3286. PubMed ID: 29491012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.
    Dumont M; Stack C; Elipenahli C; Jainuddin S; Gerges M; Starkova N; Calingasan NY; Yang L; Tampellini D; Starkov AA; Chan RB; Di Paolo G; Pujol A; Beal MF
    Hum Mol Genet; 2012 Dec; 21(23):5091-105. PubMed ID: 22922230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.
    Dillon LM; Hida A; Garcia S; Prolla TA; Moraes CT
    PLoS One; 2012; 7(9):e44335. PubMed ID: 22962610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma.
    Chiang MC; Chen CM; Lee MR; Chen HW; Chen HM; Wu YS; Hung CH; Kang JJ; Chang CP; Chang C; Wu YR; Tsai YS; Chern Y
    Hum Mol Genet; 2010 Oct; 19(20):4043-58. PubMed ID: 20668093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.
    Török R; Kónya JA; Zádori D; Veres G; Szalárdy L; Vécsei L; Klivényi P
    Cell Mol Neurobiol; 2015 Mar; 35(2):293-301. PubMed ID: 25319408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.
    Phan J; Hickey MA; Zhang P; Chesselet MF; Reue K
    Hum Mol Genet; 2009 Mar; 18(6):1006-16. PubMed ID: 19124532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGC-1alpha, a new therapeutic target in Huntington's disease?
    McGill JK; Beal MF
    Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrodia elata alleviates mutant huntingtin aggregation through mitochondrial function and biogenesis mediation.
    Huang CL; Wang KC; Yang YC; Chiou CT; Tan CH; Lin YL; Huang NK
    Phytomedicine; 2018 Jan; 39():75-84. PubMed ID: 29433686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal Muscle-Specific Overexpression of PGC-1α Induces Fiber-Type Conversion through Enhanced Mitochondrial Respiration and Fatty Acid Oxidation in Mice and Pigs.
    Zhang L; Zhou Y; Wu W; Hou L; Chen H; Zuo B; Xiong Y; Yang J
    Int J Biol Sci; 2017; 13(9):1152-1162. PubMed ID: 29104506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice.
    Wang Y; Li X; Guo Y; Chan L; Guan X
    Metabolism; 2010 Jul; 59(7):967-76. PubMed ID: 20015518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1α.
    Lucas EK; Dougherty SE; McMeekin LJ; Trinh AT; Reid CS; Cowell RM
    PLoS One; 2012; 7(8):e42878. PubMed ID: 22916173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.
    Tsunemi T; La Spada AR
    Prog Neurobiol; 2012 May; 97(2):142-51. PubMed ID: 22100502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Brown and White Adipocyte Transcriptome by the Transcriptional Coactivator NT-PGC-1α.
    Kim J; Fernand VE; Henagan TM; Shin J; Huypens P; Newman S; Gettys TW; Chang JS
    PLoS One; 2016; 11(7):e0159990. PubMed ID: 27454177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.